Fecal calprotectin level correlated with both endoscopic severity and disease extent in ulcerative colitis-Reference-Cited by-同舟云学术

Fecal calprotectin level correlated with both endoscopic severity and disease extent in ulcerative colitis

Published:2016-04-12 Issue:1 Volume:16 Page:
ISSN:1471-230X
Container-title:BMC Gastroenterology
language:en
Short-container-title:BMC Gastroenterol

Author:

Kawashima Kousaku,Ishihara Shunji,Yuki Takafumi,Fukuba Nobuhiko,Oshima Naoki,Kazumori Hideaki,Sonoyama Hiroki,Yamashita Noritsugu,Tada Yasumasa,Kusunoki Ryusaku,Oka Akihiko,Mishima Yoshiyuki,Moriyama Ichiro,Kinoshita Yoshikazu

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12876-016-0462-z

Reference33 articles.

1. Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2005;353:2462–76.

2. Armuzzi A, Pugliese D, Danese S, Rizzo G, Felice C, Marzo M, et al. Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis. Inflamm Bowel Dis. 2014;20:1368–74.

3. Sandborn WJ, van Assche G, Reinisch W, Colombel JF, D’Haens G, Wolf DC, et al. Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis. Gastroenterology. 2012;142:257–65.

4. Reinisch W, Sandborn WJ, Panaccione R, Huang B, Pollack PF, Lazar A, et al. 52-week efficacy of adalimumab in patients with moderately to severely active ulcerative colitis who failed corticosteroids and/or immunosuppressants. Inflamm Bowel Dis. 2013;19:1700–09.

5. Danese S, Fiorino G, Peyrin-Biroulet L, Lucenteforte E, Virgili G, Moja L, et al. Biological agents for moderately to severely active ulcerative colitis: a systematic review and network meta-analysis. Ann Intern Med. 2014;160:704–11.

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deep mucosal healing in ulcerative colitis: how deep is better?;Frontiers in Medicine;2024-08-02

2. Assessment of IBD disease activity by Interleukin-6 and serum amyloid A in relation with fecal calprotectin and endoscopic indices;Arab Journal of Gastroenterology;2024-08

3. Determining the optimal route of faecal microbiota transplant in patients with ulcerative colitis: the STOP-Colitis pilot RCT;Efficacy and Mechanism Evaluation;2024-08

4. Fecal calprotectin in pediatric gastrointestinal diseases: Pros and cons;World Journal of Clinical Pediatrics;2024-06-09

5. Enhancing Calprotectin’s Predictive Power as a Biomarker of Endoscopic Activity in Ulcerative Colitis: A Machine Learning Use Case;Biomedicines;2024-02-20